Is a pleomorphic adenoma (benign salivary gland tumor) cancerous?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is a Pleomorphic Adenoma Cancerous?

No, pleomorphic adenoma is not cancerous - it is the most common benign salivary gland tumor, accounting for 60-70% of all parotid tumors. 1

Characteristics of Pleomorphic Adenoma

Pleomorphic adenoma is characterized by:

  • Benign neoplasm that primarily affects the salivary glands 1
  • Most commonly found in the parotid gland, but can also occur in minor salivary glands 2
  • Slow-growing tumor that can cause significant morbidity if left untreated 3
  • Distinguished by its "pleomorphic" or varied histological architecture 2

Diagnostic Features

Pleomorphic adenomas have specific characteristics that help differentiate them from malignant tumors:

  • Typically present as firm, painless masses 4
  • MRI with and without IV contrast is the preferred imaging modality 1
  • Diagnosis is confirmed through histopathological examination following biopsy 5
  • Cytological analysis via fine-needle aspiration can provide preoperative diagnosis 5

Potential for Malignant Transformation

While pleomorphic adenomas are benign, they have important clinical implications:

  • In rare cases, they can undergo malignant transformation to become carcinoma ex pleomorphic adenoma (CXPA) 6
  • CXPA is an aggressive malignancy that develops within a pre-existing pleomorphic adenoma 6
  • The risk of malignant transformation increases with the duration of the tumor 6
  • Patients with CXPA have a poorer prognosis, with 3-year overall survival of 39% and 5-year survival of 30% 6

Management Approach

The standard treatment for pleomorphic adenoma is:

  • Complete surgical excision with adequate margins 1
  • For tumors in major salivary glands: superficial or total parotidectomy with facial nerve preservation 3
  • For tumors in minor salivary glands: wide radical resection 5
  • Enucleation or local dissection is not recommended due to capsular abnormalities and risk of recurrence 1

Important Considerations

  • Proper surgical technique is crucial as incomplete removal can lead to recurrence 2
  • Recurrence rates after appropriate surgery are less than 5% 3
  • Radiotherapy may be indicated for cases with positive margins, unresectable tumors, or multifocal recurrences 3
  • Pleomorphic adenomas can sometimes mimic malignancy histologically, creating diagnostic challenges 7

Follow-up Care

After treatment, patients should undergo:

  • Monthly surveillance during the first 6 months 1
  • Gradually decreasing frequency of follow-up visits (3-monthly, then 4-monthly, then 6-monthly for 3-4 years, then annually) 1
  • Regular chest X-rays (AP and lateral) every 6 months initially, then yearly 1

Proper diagnosis and complete surgical excision are essential for preventing recurrence and the rare possibility of malignant transformation of pleomorphic adenomas.

References

Guideline

Salivary Gland Tumor Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pleomorphic Adenoma Of Minor Salivary Glands.

Journal of Ayub Medical College, Abbottabad : JAMC, 2016

Research

Salivary gland pleomorphic adenoma.

American journal of clinical oncology, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.